ChalmersD., “Medical Research: Future Directions in the Genome Era,” in JolyY.KnoppersB. M., eds., Routledge Handbook of Medical Law and Ethics (Routledge: New York, 2015): At 303–318.
2.
Id., at 312.
3.
For scope of biobanking, see RynningE., “Legal Challenges and Strategies in the Regulation of Research Biobanking,” in SolbakkJ. H.HolmS.HofmannB., eds., The Ethics of Research Biobanking (London: Springer US, 2009): At 281[hereinafter cited as Rynning].
4.
Biobanks and the Public – Governing Biomedical Research Resources in Europe, A Report from the BBMRI Project (2013): At 16 [hereinafter cited as BBMRI]; Public Population Project in Genomics and Society, “Biobank Lexicon,”available at <http://www.p3g.org/biobank-lexicon/> (last visited March 6, 2015).
5.
KnoppersB. M.ZawatiM. H.KirbyE., “Sampling Populations of Humans across the World: ELSI Issues,”Annual Review of Genomics and Human Genetics13 (2012): 395–413, at 397–399.
6.
TasséA.-M., “From ICH to IBH in Biobanking? A Legal Perspective on Harmonization, Standardization and Unification,”Studies in Ethics, Law, and Technology7, no. 1 (2013): 1–15.
7.
OderkirkJ.RonchiE.KlazingaN., “International Comparisons of Health System Performance among OECD Countries: Opportunities and Data Privacy Protection Challenges,”Health Policy112, nos. 1–2 (2013): 9–18, at 12–15.
8.
Di IorioC. T., “Cross-Border Flow of Health Information: Is ‘Privacy by Design’ Enough? Privacy Performance Assessment in EURIBOD,”European Journal of Public Health23, no. 2 (2013): 247–253, at 247.
9.
See Rynning, supra note 3, at 278.
10.
KunerC., Transborder Data Flows and Data Privacy Law (Oxford: Oxford University Press, 2013): At 63 [hereinafter cited as Kuner].
11.
ChenH.PangT., “A Call for Global Governance of Biobanks,”Bulletin of the World Health Organization93, no. 2 (2015): 113–117.
UN General Assembly, Universal Declaration of Human Rights (1948), at Article 12, available at <http://www.un.org/en/documents/udhr/> (last visited October 15, 2015) [hereinafter cited as Universal Declaration of Human Rights].
See Universal Declaration of Human Rights, supra note 14, at Article 29(2).
18.
European Parliament, Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the Protection of Individuals with Regard to the Processing of Personal Data and on the Free Movement of Such Data (1995), available at <http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31995L0046:en:HTML> (last visited October 15, 2015).
19.
ReichelJ., “Need for Legitimate Regulatory Regime in Bioethics: A Global and European Perspective,”Missouri Law Review78, no. 2 (2013): 465–487, at 483.
Council for International Organizations of Medical Sciences, International Ethical Guidelines for Epidemiological Studies (2009) [hereinafter cited as CIOMS Epi Guidelines]; see also, CIOMS and WHO, International Ethical Guidelines for Biomedical Research Involving Human Subjects (2002), available at <http://www.cioms.ch/publications/layout_guide2002.pdf> (last visited October 15, 2015).
OECD, OECD Principles and Guidelines for Access to Research Data from Public Funding (2007), available at <http://www.oecd.org/sti/sci-tech/38500813.pdf> (last visited October 15, 2015) [hereinafter cited as Data from Public Funding Guidelines].
30.
OECD, OECD Recommendation on Human Biobanks and Genetic Research Databases (2009) [Biobanking Guidelines].
World Medical Association, Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects (2008), available at <http://www.wma.net/en/30publications/10policies/b3/> (last visited October 15, 2015) [hereinafter cited as Declaration of Helsinki].
33.
LowranceW. W., Privacy, Confidentiality, and Health Research (Cambridge: Cambridge University Press, 2012): At 54–55 [hereinafter cited as Lowrance].
34.
See Declaration of Helsinki, supra note 32, at Article 9.
35.
ElgerB., ed., Ethical Issues of Human Genetic Databases: A Challenge to Classical Health Research Ethics? (Surrey: Ashgate Publishing Limited, 2010): At 4 [hereinafter cited as Elger].
36.
World Medical Association, Declaration on Ethical Considerations regarding Health Databases (2002), at Article 4, available at <http://www.wma.net/en/30publications/10policies/d1/> (last visited October 15, 2015).
37.
HUGO Ethics Committee, Statement on DNA Sampling: Control and Access (1998), available at <http://www.hugo-international.org/img/dna_1998.pdf> (last visited October 15, 2015) [hereinafter cited as 1998 HUGO Statement]; HUGO Ethics Committee, Statement on Human Genomic Databases (2002), available at <http://www.hugo-international.org/img/genomic_2002.pdf> (last visited October 15, 2015) [hereinafter cited as 2002 HUGO Statement].
P3G-IPAC website, available at <http://p3g.org/ipac> (last visited October 15, 2015).
41.
International Society for Biological and Environmental Repositories (ISBER), Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research (2012), available at <http://c.ymcdn.com/sites/www.isber.org/resource/resmgr/Files/ISBER_Best_Practices_3rd_Edi.pdf> (last visited October 15, 2015) [hereinafter cited as ISBER Best Practices]; see also, World Health Organization and International Agency for Research on Cancer, Common Minimum Technical Standards and Protocols for Biological Resource Centres Dedicated to Cancer Research, Working Group Reports (2007): At vol. 2; BBMRI, supra note 4.
42.
TaylorM., Genetic Data and the Law: A Critical Perspective on Privacy Protection (Cambridge: Cambridge University Press, 2013): At 20.
43.
LandauS., “Control Use of Data to Protect Privacy,”Science347, no. 6221 (2015): 504–506, at 504.
44.
For samples, see ISBER Best Practices, supra note 41, at L2.200; ForsbergJ. S.HanssonM. G.EversK., “International Guidelines on Biobank Research Leave Researchers in Ambiguity: Why Is This So?”European Journal of Epidemiology28, no. 6 (2013): 449–451, at 449 [hereinafter cited as Forsberg].
45.
See Declaration of Helsinki, supra note 32, at Article 26.
46.
See CIOMS Guidelines, supra note 26, at Articles 4, 18.
47.
See UDHGHR, supra note 20, at Article 5(b); See IGHGD, supra note 21, at Article 6(d); see UDBHR, supra note 23, at Article 6(2).
48.
TzanouM., “Data Protection as a Fundamental Right Next to Privacy? ‘Reconstructing’ a Not so New Right,”International Data Privacy Law3, no. 2 (2013): 88–99, at 89.
49.
KosseimP.BradyM., “Policy by Procrastination: Secondary Use of Electronic Health Records for Health Research Purposes,”McGill Journal of Law and Health2, no. 1 (2008): 5–45, at 17 [hereinafter cited as Kosseim].
50.
See Elger, supra note 35.
51.
See UDHGHR, supra note 20, at Article 6(2).
52.
See IGHGD, supra note 21, at Article 2; See UDHGHR, supra note 20, at Article 6(d).
53.
MasterZ.NelsonE.MurdochB.CaulfieldT., “Biobanks, Consent and Claims of Consensus,”Nature Methods9, no. 9 (2012): 885–888, at 885.
54.
SteinsbekkK. S.Kåre MyskjaB.SolbergB., “Broad Consent Versus Dynamic Consent in Biobank Research: Is Passive Participation an Ethical Problem?”European Journal of Human Genetics21, no. 9 (2013): 897–902, at 897.
HofmannB., “Broadening Consent – and Diluting Ethics?”Journal of Medical Ethics35, no. 2 (2009): 125–129, at 128.
58.
GreelyH. T., “The Uneasy Ethical and Legal Underpinnings of Large-Scale Genomic Biobanks,”Annual Review of Genomics and Human Genetics8 (2007): 343–364, at 358.
59.
CaulfieldT.KnoppersB. M., Consent, Privacy & Research Biobanks, Policy Directions Brief Number 1, 2009–2010 Series on Genetic Information, Genome Canada (January 26, 2010): 1–10, at 4–5, available at <http://www.genomecanada.ca/medias/pdf/en/GPS-Policy-Directions-Brief.pdf> (last visited October 15, 2015); NomperA., Open Consent: A New Form of Informed Consent for Population Genetic Databases (Tartu: Tartu ülikooli kirjastus, 2005).
60.
KnoppersB. M.Abdul-Rahman (Zawati)M. H., “Biobanks in the Literature,” in ElgerB., eds., Ethical Issues in Governing Biobanks: Global Perspectives (Aldershot: Ashgate, 2008): At 14 [hereinafter cited as Knoppers].
61.
See Lowrance, supra note 33, at 75–76, 118.
62.
KnoppersB. M., “Framing Genomics, Public Health Research and Policy: Points to Consider,”Public Health Genomics13, no. 4 (2010): 224–234, at 231.
63.
See KnoppersAbdul-Rahman, supra note 60.
64.
UNESCO, Report of the International Bioethics Committee of UNESCO (IBC) on Consent, 2008, at para 54 [hereinafter cited as UNESCO IBC].
65.
See OECD Biobanking Guidelines, supra note 30; ISBER Best Practices, supra note 41, at 28; See also ISBER Best Practices, supra note 41, at L2.200.
66.
See 1998HUGO Statement, supra note 37; 2002HUGO Statement, supra note 37, at Rec 4(c); UNESCO IBC, supra note 64, at para. 50.
67.
See Biobanking Guidelines, supra note 30, at 4E, F.
68.
See 2002HUGO Statement, supra note 37, at 4d; Biobanking Guidelines, supra note 30, at 61, Article 4.4.
69.
GA4GH Framework, supra note 35, at “Core Elements”.
70.
See UDBHR, supra note 23, at Article 6(2).
71.
MelhamK., “The Evolution of Withdrawal: Negotiating Research Relationships in Biobanking,”Life Sciences, Society and Policy10, no. 16 (2014): 1–13; see ISBER Best Practices, supra note 41, at L2.200.
72.
See IDHGD, supra note 21, at Article 9(a); CIOMS Epi Guidelines, supra note 26, at Guideline 5; OECD Biobanking Guidelines, supra note 30, at 42–43.
73.
KayeJ., “The Tension between Data Sharing and the Protection of Privacy in Genomics Research,” in Mascalzoni, ed., Ethics, Law and Governance of Biobanking (New York: 2015): 101–120, at 105.
74.
Taylor, supra note 42, at 94.
75.
See IDHGD, supra note 21, at Article 16(a–b).
76.
See UNESCO IBC, supra note 64, at para 53.
77.
See OECD Biobanking Guidelines, supra note 30, at Article 33.
78.
See Declaration of Helsinki, supra note 32, at Article 32.
79.
See 1998HUGO Statement, supra note 37.
80.
See GA4GH Framework, supra note 39, at “Core Elements.”
81.
See CIOMS Epi Guidelines, supra note 26, at Guideline 4 b).
82.
See Kaye, supra note 73, at 112.
83.
SchmidtH.CallierS., “How Anonymous Is ‘Anonymous’? Some Suggestions towards a Coherent Universal Coding System for Genetic Samples,”Journal of Medical Ethics38, no. 5 (2012): 304–309, at 304.
84.
See Lowrance, supra note 33, at 87.
85.
KnoppersB. M.ChadwickR., “Human Genetic Research: Emerging Trends in Ethics,”Nature Reviews Genetics6, no. 1 (2005): 75–79, at 925.
See OECD Biobanking Guidelines, supra note 30, at 14(c-e); 1998HUGO Statement, supra note 37.
89.
See OECD Biobanking Guidelines, supra note 30, Annotation at 37; OECD Data from Public Funding Guidelines, supra note 29, at D.
90.
ThorogoodA., “An Implementation Framework for the Feedback of Individual Research Results and Incidental Findings in Research,”BMC Medical Ethics15, no. 88 (2014): 1–13, at 9.
91.
See IDHGD, supra note 21, at Preamble.
92.
See El Emam, supra note 82, at 3.
93.
See Kosseim, supra note 49, at 28.
94.
See Lowrance, supra note 33, at 118.
95.
GymrekM., “Identifying Personal Genomes by Surname Inference,”Science339, no. 6112 (2013): 321–324.
96.
See OECD Biobanking Guidelines, supra note 30, at 6.4.
97.
See ISBER Best Practices, supra note 41, at L2.300.
98.
See, e.g., OECD Data Protection Guidelines, supra note 28, at 24.
99.
See OECD Biobanking Guidelines, supra note 30, at 6.3.
100.
GA4GH Framework, supra note 39, at “Core Elements.”
101.
Id., at 5C, 22.22; ISBER Best Practices supra note 41, at M2.100; GA4GH Framework, supra note 39; Madrid Resolution, supra note 32, at 10.1.
102.
See OECD Biobanking Guidelines, supra note 30, at 7A, 6.8; GA4GH Framework, supra note 39, at “Accountability.”
103.
See OECD Biobanking Guidelines, supra note 30, at 2.3,7.3.
104.
See ISBER Best Practicessupra note 41, at M2.200.
105.
Id.
106.
See, e.g., OECD Data Protection Guidelines, supra note 28; Madrid Resolution, supra note 32, at 10.2; OECD Biobanking Guidelines, supra note 30, at 66; GA4GH Framework, supra note 39 which imposes some of these as freestanding duties on all of its members; ISBER Best Practices, supra note 41, at M2.610 (sample), M2.620 (data).
107.
See, e.g., OECD Data Protection Guidelines, supra note 28, at 16; Madrid Resolution, supra note 32, at 10.1.
See Universal Declaration of Human Rights, supra note 14, at Article 27; UN General Assembly, International Covenant on Economic, Social and Cultural Rights, 1966, available at <http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx> (last visited October 15, 2015).
111.
See UDHGHR, supra note 20, at Article 24; See IDHGD, supra note 21, at Article 18.
EnderinkM.ChinG., “The End of Privacy: From Big Data to Ubiquitous Internet Connections, Technology Empowers Researchers and the Public – but Makes Traditional Notions of Privacy Obsolete,”Science347, no. 6221 (2015): 490–491, at 490.